Clinical Trial Update: Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating Compound Kushen Injection combined with Pabolizumab for cervical cancer (cervical adenocarcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Compound Kushen Injection (Kushen (Sophora flavescens) extract injection containing matrine/oxymatrine)
• Pabolizumab

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN